Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06915480 · ClinicalTrials.gov registry record · Phase 3
Reducing Missed Appointments
A Phase 3 study of Neurodevelopmental Disorders, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 5,000
- Enrollment target
- 1
- Study location
NCT06915480: Recruiting Phase 3 study of Neurodevelopmental Disorders, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.
NCT06915480 is a Phase 3 study of Neurodevelopmental Disorders that is actively recruiting participants, run by Hugo W. Moser Research Institute at Kennedy Krieger. The registered enrollment target is 5,000 participants, above the 396-participant average among 27 other Neurodevelopmental Disorders trials with a reported enrollment target (1163% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06915480, a Phase 3 study of Neurodevelopmental Disorders, is actively recruiting participants, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 5,000 participants
- Enrollment target
- 1
- Study location
Study Summary
There are four goals of this project: (1) To examine the impact of different appointment reminder messages on appointment attendance; (2) to determine the added benefit of a patient navigator reaching out in advance of appointments to families at elevated risk of missing their appointment, and determine the most common barriers families face in appointment attendance; (3) to evaluate which patients are at highest risk of missing their appointment, and to determine the effectiveness of the intervention trial across different patient risk levels; and (4) to examine if the missing appointment interventions increase the socioeconomic diversity patients.
Primary Outcome
Proportion of appointments that are neither kept nor cancelled
Conditions Studied
Interventions
- BEHAVIORAL Reminder message and patient navigation
Study Locations (1)
Maryland
- Kennedy Krieger Institute - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2025-12-29 |
| Est. Completion | 2027-12-01 |
| Phase | Phase 3 |
What NCT06915480 shows while recruiting
NCT06915480 is an interventional study that assigns participants to a tested intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus, above the 396-participant average among 27 other Neurodevelopmental Disorders trials with a reported enrollment target (1163% higher).
The record links to 1 condition, with Neurodevelopmental Disorders appearing as the primary indexed condition, and to 1 intervention - of which Reminder message and patient navigation is the first listed.
NCT06915480 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT06915480 about?
NCT06915480 is a clinical study titled "Reducing Missed Appointments". There are four goals of this project: (1) To examine the impact of different appointment reminder messages on appointment attendance; (2) to determine the added benefit of a patient navigator reaching out in advance of appointments to families at elevated risk of missing their appointment, and deter...
What is the current status of trial NCT06915480?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 5,000 participants. The study started on 2025-12-29. Estimated completion is 2027-12-01.
What conditions does trial NCT06915480 study?
This clinical trial studies the following conditions: Neurodevelopmental Disorders.
What interventions are being tested in trial NCT06915480?
The interventions under investigation include: Reminder message and patient navigation (BEHAVIORAL).
Who is sponsoring clinical trial NCT06915480?
This trial is sponsored by Hugo W. Moser Research Institute at Kennedy Krieger, which has 73 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06915480 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neurodevelopmental Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06915480's enrollment target sits among peer trials
5,000 1st of 27 higher than 27 of 27 other Neurodevelopmental Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Neurodevelopmental Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Physical Activity and Community EmPOWERment Project
RECRUITING · NA
-
SQUED™ Series 28.1 Home-use and Treatment of Autowave Reverberator of Autism
RECRUITING
-
Rett Syndrome Registry
RECRUITING
-
Motor-voice Assessment in Infants (MAMI)
RECRUITING
-
Natural History Study of GEMIN-5 Related Neurodevelopmental Disorder
RECRUITING
-
Fetal Cerebrovascular Autoregulation in Congenital Heart Disease and Association With Neonatal Neurobehavior
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00575081 · 5,000 participants
Physiological Brain Atlas Development
- NCT00736749 · 5,000 participants
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- NCT00900198 · 5,000 participants
Collection of Tissue Samples for Cancer Research
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI